These results demonstrate that remodelin inhibits HNSCC tumorigenesis by increasing infiltrated CD8+ T cells and impairing angiogenesis and Treg recruitment in HNSCC tissues to reshape the tumor microenvironment, highlighting NAT10’s role as a potential therapeutic target (Fig. 8). Here, NAT10 is linked to neoplasm.